| meta-analysis | Q815382 |
| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Olivier Bruyère | Q29839802 |
| Gabriel Herrero-Beaumont | Q42186933 | ||
| P2093 | author name string | Eliakim R | |
| Audran M | |||
| Reginster JY | |||
| Moore A | |||
| Haim M | |||
| Bouvenot G | |||
| Ethgen O | |||
| Rabenda V | |||
| Richy F | |||
| P2860 | cites work | Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis | Q24655364 |
| Bias in meta-analysis detected by a simple, graphical test | Q24685585 | ||
| Assessing the quality of reports of randomized clinical trials: is blinding necessary? | Q27860973 | ||
| Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group | Q28138338 | ||
| Empirical evidence of design-related bias in studies of diagnostic tests | Q30776370 | ||
| Gastrointestinal safety and tolerance of ibuprofen at maximum over-the-counter dose | Q33420778 | ||
| A double blind, multicentre, placebo controlled trial of lornoxicam in patients with osteoarthritis of the hip and knee | Q33567478 | ||
| Epidemiology of NSAID induced gastrointestinal complications. | Q33606443 | ||
| Non-aspirin, non-steroidal anti-inflammatory drugs for osteoarthritis of the knee | Q33907655 | ||
| A systematic survey of 13 randomized trials of non-steroidal anti-inflammatory drugs for the prevention of heterotopic bone formation after major hip surgery | Q33942168 | ||
| Observational study of upper gastrointestinal haemorrhage in elderly patients given selective cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs | Q34093824 | ||
| Approaches to nonsteroidal anti-inflammatory drug use in the high-risk patient | Q34141269 | ||
| Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis | Q34520598 | ||
| How study design affects outcomes in comparisons of therapy. I: Medical | Q34530105 | ||
| Nonsteroidal anti-inflammatory drugs and hospitalization for gastroesophageal bleeding in the elderly | Q34689067 | ||
| Double-blind, placebo-controlled comparison of the safety and efficacy of orally administered etodolac and nabumetone in patients with active osteoarthritis of the knee | Q34732423 | ||
| Meta-analysis of risk factors for peptic ulcer. Nonsteroidal antiinflammatory drugs, Helicobacter pylori, and smoking | Q34737659 | ||
| Coxibs: Evolving role in pain management | Q35045103 | ||
| Inhaled corticosteroids effects on bone in asthmatic and COPD patients: a quantitative systematic review | Q35121392 | ||
| Adaptation in the Pharmaceutical Industry, with Particular Reference to Gastrointestinal Drugs and Diseases | Q35192811 | ||
| Gastrointestinal tolerability of meloxicam and piroxicam: a double-blind placebo-controlled study | Q35802532 | ||
| The impact of research quality and study design on epidemiologic estimates of the effect of nonsteroidal anti-inflammatory drugs on upper gastrointestinal tract disease | Q35877977 | ||
| Association of upper gastrointestinal toxicity of non-steroidal anti-inflammatory drugs with continued exposure: cohort study | Q36247207 | ||
| Identifying relevant studies for systematic reviews | Q36888457 | ||
| Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis | Q37363098 | ||
| A review of gastric ulcer and gastroduodenal injury in normal volunteers receiving aspirin and other non-steroidal anti-inflammatory drugs | Q38717957 | ||
| Nonsteroidal antiinflammatory drugs and the gastrointestinal tract. The double-edged sword | Q40567516 | ||
| Nonsteroidal anti-inflammatory drugs and the incidence of hospitalizations for peptic ulcer disease in elderly persons | Q40618049 | ||
| Second-line drug therapy for rheumatoid arthritis | Q40736923 | ||
| Nonsteroidal anti-inflammatory drug-induced gastrointestinal toxicity: new insights into an old problem | Q41371690 | ||
| Gastrointestinal events in patients prescribed non-steroidal anti-inflammatory drugs: a controlled study using record linkage in Tayside | Q41881920 | ||
| A comparison of Naprelan and Naprosyn in the treatment of osteoarthritis of the knee | Q43665411 | ||
| Gastrointestinal-related healthcare resource usage associated with a fixed combination of diclofenac and misoprostol versus other NSAIDs | Q43682732 | ||
| Diclofenac, a nonsteroidal anti-inflammatory drug, decreases proteinuria in some glomerular diseases: a controlled study | Q44939365 | ||
| A metaanalysis of severe upper gastrointestinal complications of nonsteroidal antiinflammatory drugs. | Q44941344 | ||
| The suppression of heterotopic ossification after total hip arthroplasty | Q45196846 | ||
| Coxibs were not cost-effective for arthritis pain in patients with average risk for ulcer complications. | Q45967646 | ||
| Nonsteroidal anti-inflammatory drug-associated gastropathy: incidence and risk factor models | Q46245351 | ||
| NSAIDs increase risk of gastrointestinal bleeding in primary care patients with dyspepsia. | Q46426930 | ||
| A randomized double-blind comparison of placebo, etodolac, and naproxen on gastrointestinal injury and prostaglandin production | Q46499838 | ||
| A cohort study (with re-sampled comparator groups) to measure the association between new NSAID prescribing and upper gastrointestinal hemorrhage and perforation. | Q50959758 | ||
| Interpreting Measures of Treatment Effect in Cancer Clinical Trials | Q56020813 | ||
| The long‐term effects of non‐steroidal anti‐inflammatory drugs in osteoarthritis of the knee: a randomized placebo‐controlled trial | Q57148297 | ||
| Effect of ibuprofen on heterotopic ossification after hip replacement | Q58077349 | ||
| Ankylosing spondylitis: what is the optimum duration of a clinical study? A one year versus a 6 weeks non-steroidal anti-inflammatory drug trial. | Q64979798 | ||
| Risk for Serious Gastrointestinal Complications Related to Use of Nonsteroidal Anti-inflammatory Drugs | Q67903664 | ||
| Naproxen prevention of heterotopic ossification after hip arthroplasty. A prospective control study of 55 patients | Q67989496 | ||
| Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs | Q68014016 | ||
| Heterotopic bone formation prevented by diclofenac. Prospective study of 100 hip arthroplasties | Q68057329 | ||
| Fatal upper gastrointestinal hemorrhage or perforation among users and nonusers of nonsteroidal anti-inflammatory drugs in Saskatchewan, Canada 1983 | Q68090334 | ||
| Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons | Q68182979 | ||
| Flurbiprofen inhibits heterotopic bone formation in total hip arthroplasty | Q68348290 | ||
| The association of nonsteroidal anti-inflammatory drugs with upper gastrointestinal tract bleeding | Q68812075 | ||
| Duodenal mucosal injury with nonsteroidal antiinflammatory drugs | Q68829424 | ||
| Risk and cost of gastrointestinal side effects associated with nonsteroidal anti-inflammatory drugs | Q69607814 | ||
| The use of indomethacin to prevent the formation of heterotopic bone after total hip replacement. A randomized, double-blind clinical trial | Q70395414 | ||
| Prevention of heterotopic ossification with tenoxicam following total hip arthroplasty: a double-blind, placebo-controlled dose-finding study | Q70797568 | ||
| Oral diclofenac in the prophylactic treatment of recurrent renal colic. A double-blind comparison with placebo | Q70807150 | ||
| Heterotopic ossification after hip arthroplasty: a randomized double-blind multicenter study tenoxicam in 147 hips | Q71043094 | ||
| Tenidap in patients with rheumatoid arthritis. A 4-week, placebo-controlled study | Q71976130 | ||
| Objective functional assessment of the efficacy of tenoxicam in the treatment of acute low back pain. A double-blind placebo-controlled study | Q72373683 | ||
| Indomethacin for prevention of heterotopic ossification. A randomized controlled study in 41 hip arthroplasties | Q72731463 | ||
| Ximoprofen in ankylosing spondylitis. A double blind placebo controlled dose ranging study | Q72838995 | ||
| Non-steroidal anti-inflammatory drugs: back to the future | Q73029279 | ||
| Efficacy and safety of meloxicam in patients with rheumatoid arthritis | Q73076866 | ||
| Safety and efficacy of meloxicam in the treatment of osteoarthritis: a 12-week, double-blind, multiple-dose, placebo-controlled trial. The Meloxicam Osteoarthritis Investigators | Q73102611 | ||
| Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial | Q73224851 | ||
| Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs | Q73224856 | ||
| Quantitative estimation of rare adverse events which follow a biological progression: a new model applied to chronic NSAID use | Q73487778 | ||
| Prevention of gastroduodenal injury induced by NSAIDs with low-dose misoprostol | Q73499636 | ||
| Risk of hospitalization for upper gastrointestinal tract bleeding associated with ketorolac, other nonsteroidal anti-inflammatory drugs, calcium antagonists, and other antihypertensive drugs | Q74071460 | ||
| A double-blind, randomized, placebo-controlled study of efficacy and tolerance of meloxicam treatment in patients with osteoarthritis of the knee | Q74325392 | ||
| Preventive effects of ibuprofen on periarticular heterotopic ossification after total hip arthroplasty. A randomized double-blind prospective study of treatment time | Q74592273 | ||
| Double-blind, placebo-controlled study on effects of diclofenac sodium and indomethacin on postprandial gastric motility in man | Q74682043 | ||
| NSAID toxicity: where are we and how do we go forward? | Q77930148 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammation | Q101991 |
| meta-analysis | Q815382 | ||
| P304 | page(s) | 759-766 | |
| P577 | publication date | 2004-07-01 | |
| P1433 | published in | Annals of the Rheumatic Diseases | Q4767876 |
| P1476 | title | Time dependent risk of gastrointestinal complications induced by non-steroidal anti-inflammatory drug use: a consensus statement using a meta-analytic approach | |
| P478 | volume | 63 |
| Q95359587 | Q95359587 |
| Q35203834 | 25 mg versus 50 mg dose of rectal diclofenac for prevention of post-ERCP pancreatitis in Japanese patients: a retrospective study |
| Q90569831 | A Comprehensive Review of Over-the-counter Treatment for Chronic Migraine Headaches |
| Q39218951 | A phase 2 study of naproxen submicron particle capsules in patients with post-surgical dental pain |
| Q92081664 | A randomized trial comparing the efficacy of single-dose and double-dose administration of rectal indomethacin in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis |
| Q37989162 | Acute gastrointestinal bleeding after percutaneous coronary intervention |
| Q26800279 | Adverse drug reactions and drug-drug interactions with over-the-counter NSAIDs |
| Q37987196 | Adverse effects associated with non-opioid and opioid treatment in patients with chronic pain |
| Q46422951 | Analysis and quantification of self-medication patterns of customers in community pharmacies in southern Chile |
| Q48269842 | Assessing adverse effects of intra-articular botulinum toxin A in healthy Beagle dogs: A placebo-controlled, blinded, randomized trial |
| Q34712231 | Assessment of diclofenac or spinal manipulative therapy, or both, in addition to recommended first-line treatment for acute low back pain: a randomised controlled trial |
| Q41296490 | Changing prevalence of Helicobacter pylori infection and peptic ulcer among dyspeptic Sardinian patients |
| Q47133048 | Characteristics of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)-Induced Small Bowel Injury Identified by Single-Balloon Endoscopy or Capsule Endoscopy. |
| Q30804806 | Clinical trial data in support of changing guidelines in osteoarthritis treatment |
| Q45980134 | Combination therapy with doxazosin and tenoxicam for the management of lower urinary tract symptoms. |
| Q37947341 | Comparative risks of non-prescription analgesics: a structured topic review and research priorities. |
| Q34585612 | Comparison of analgesic and anti-inflammatory efficacy of selective and non-selective cyclooxygenase-2 inhibitors in dental implant surgery |
| Q37321437 | Comparison of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 (COX-2) inhibitors use in Australia and Nova Scotia (Canada) |
| Q83500750 | Design and synthesis of novel cyclooxygenase-1 inhibitors as analgesics: 5-amino-2-ethoxy-N-(substituted-phenyl)benzamides |
| Q36516256 | Effect of Premedication with Indomethacin and Ibuprofen on Postoperative Endodontic Pain: A Clinical Trial. |
| Q37588841 | Evolving guidelines in the use of topical nonsteroidal anti-inflammatory drugs in the treatment of osteoarthritis |
| Q36332697 | Gastrointestinal toxicity among patients taking selective COX-2 inhibitors or conventional NSAIDs, alone or combined with proton pump inhibitors: a case-control study. |
| Q39315179 | Guidelines for the use of nonsurgical interventions in osteoarthritis management |
| Q47862254 | Implementation of a proton pump inhibitor stewardship program |
| Q64251945 | In Silico Evaluation of Ibuprofen and Two Benzoylpropionic Acid Derivatives with Potential Anti-Inflammatory Activity |
| Q36429634 | Long-term tolerability of topical diclofenac sodium 1% gel for osteoarthritis in seniors and patients with comorbidities |
| Q83477164 | Low-dose rectal diclofenac for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a randomized controlled trial |
| Q39219199 | Lower-dose diclofenac submicron particle capsules provide early and sustained acute patient pain relief in a phase 3 study |
| Q36262489 | Management of co-morbidities and general medical conditions in patients with rheumatoid arthritis |
| Q90074709 | Modulation of the In Vivo Inflammatory Response by Pro- Versus Anti-Inflammatory Intervertebral Disc Treatments |
| Q37447421 | N'-[(E)-4-Meth-oxy-benzyl-idene]-2-(5-meth-oxy-2-methyl-1H-indol-3-yl)acetohydrazide |
| Q64912021 | NSAID, antiaggregant, and/or anticoagulant-related upper gastrointestinal bleeding: Is there any change in prophylaxis rate after a 10-year period? |
| Q36384721 | NSAID-associated adverse effects and acid control aids to prevent them: a review of current treatment options |
| Q43274525 | NSAIDs and the gastrointestinal tract |
| Q33371808 | Non-steroidal anti-inflammatory drugs, Cyclooxygenase-2 inhibitors and paracetamol use in Queensland and in the whole of Australia |
| Q34565551 | Nonsteroidal anti-inflammatory drug use in ankylosing spondylitis--a population-based survey |
| Q39184228 | Onset and durability of pain relief in knee osteoarthritis: Pooled results from two placebo trials of naproxen/esomeprazole combination and celecoxib |
| Q50046112 | Outcomes From a Pharmacist - led Proton Pump Inhibitor Stewardship Program at a Single Institution |
| Q37949845 | Pharmacologic treatment of knee osteoarthritis in athletic women |
| Q27023475 | Piroxicam-β-cyclodextrin: a GI safer piroxicam |
| Q35909069 | Preemptive Genotyping of CYP2C8 and CYP2C9 Allelic Variants Involved in NSAIDs Metabolism for Sickle Cell Disease Pain Management |
| Q35029004 | Quality measures for the care of patients with lateral epicondylalgia |
| Q36832546 | Recent developments in crystal-induced inflammation pathogenesis and management. |
| Q39354761 | Review article: a practical approach to the clinical management of NSAID enteropathy |
| Q53411662 | Rheological and textural properties of microemulsion-based polymer gels with indomethacin. |
| Q26765518 | Role of endoplasmic reticulum stress in drug-induced toxicity |
| Q38541866 | Safety and efficacy of paracetamol and NSAIDs in osteoarthritis: which drug to recommend? |
| Q45022824 | Safety of celecoxib compared with placebo and non-selective NSAIDs: cumulative meta-analysis of 89 randomized controlled trials |
| Q37165495 | Safety of the nonselective NSAID nabumetone : focus on gastrointestinal tolerability |
| Q37794972 | Should nonsteroidal anti-inflammatory drugs (NSAIDs) be prescribed to the older adult? |
| Q53533725 | Synergistic interaction between meloxicam and aminoguanidine in formalin-induced nociception in mice. |
| Q64958749 | The Effectiveness of the Rectal Administration of Low-dose Diclofenac for the Prevention of Post-endoscopic Retrograde Cholangiopancreatography Pancreatitis. |
| Q26777618 | The role of inflammation-related genes in osteoarthritis |
| Q89909576 | The role of serratiopeptidase in the resolution of inflammation |
| Q39332341 | The selective and non-selective cyclooxygenase inhibitors valdecoxib and piroxicam induce the same postoperative analgesia and control of trismus and swelling after lower third molar removal |
| Q37523942 | The treatment and prevention of knee osteoarthritis: a tool for clinical decision-making. |
| Q37810415 | Topical Nonsteroidal Anti-Inflammatory Drugs for Osteoarthritis |
| Q37902642 | Topical therapies for osteoarthritis |
| Q41477354 | Underuse of proton-pump inhibitors in older patients newly starting NSAID treatment |
| Q44097676 | Underutilization of gastroprotective drugs in patients receiving non-steroidal anti-inflammatory drugs |
| Q37415494 | Utilization of gastroprotective strategies for nonsteroidal anti-inflammatory drug-induced gastrointestinal events in a major teaching hospital |
| Q35605617 | Validation of the International Classification of Functioning, Disability and Health (ICF) Core Set for rheumatoid arthritis from the patient perspective using focus groups. |
| Q88336488 | [Pharmacological treatment of osteoarthritis-related pain] |
Search more.